FACULTY


MELANOMA BRIDGE 2017
November 30th - December 2nd 2017


Invited Faculty


Sanjiv Agarwala
Chief of Medical oncology and Hematology, St. Luke’s University Hospital and Temple University, Bethlehem, Pennsylvania

Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy

Carlo Bifulco
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon

Gerardo Botti
National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Corrado Caracò
Director of Department Melanoma, Soft Tissue, Muscle-Skeletal and Head-Neck, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Michael Davies
Associate Professor, Department of Melanoma Medical Oncology, Department of Systems Biology, University of Texas MD Anderson Cancer Center, Texas

Sandra Demaria
New York University School of Medicine and NYU Langone Medical Center Alexandria Center for Life Sciences, New York, New York

Reinhard Dummer
Professor of Dermatology, University of Zurich Hospital, Department of Dermatology, Zurich, Switzerland

Soldano Ferrone
Massachusetts General Hospital, Boston, Massachusetts

Claus Garbe
Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen, Germany

Thomas F. Gajewski
Oncology and Immunology Professor, Department of Pathology and Department of Medicine, Section of Hematology/Oncology, Chicago, Illinois

Jeffrey Gershenwald
Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

Omid Hamid
Chief, Translational Research and Immunotherapy, Director, Melanoma Therapeutics, The Angeles Clinic and Research Institute, Santa Monica, California, US

John Kirkwood
Usher Professor of Medicine, Dermatology & Translational Science, Director, Melanoma and Skin Cancer Program, Department of Medicine, Division of Hematology/Oncology, Univerisy of Pittsburgh, Pennsylvania, US

Jason Luke
Assistant Professor of Medicine, The University of Chicago Medicine, Chicago, Illinois, US

Francesco M. Marincola
Distinguished Research Fellow Immuno Oncology, Redwood City, California

Giuseppe Masucci
Professor, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden

Janice Mehnert
Director, Phase I and Developmental Therapeutics Program, Cancer Institute of New Jersey, New Brunswick, New Jersey

Nicola Mozzillo
Director of the Department of Surgical Oncology B, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Giuseppe Palmieri
Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy

Michael Postow
Memorial Sloan Kettering Cancer Center, New York

Igor Puzanov
Associate Professor of Medicine, Associate Director of Phase I Drug Development, Director, Melanoma Clinical Research, Director of Early Clinical Trials and Developmental Therapeutics, Director of Melanoma Program, Professor of Medicine and Oncology at Roswell Park Cancer Institute in Buffalo, New York

Merrick Ross
Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

Stephen Schoenberger
Professor of Immunology, La Jolla Institute for allergy and immunology, University of California, San Diego, California

Ryan J. Sullivan
Assistant Professor, Medicine, Harvard Medical School, Assistant Professor, Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts

Magdalena Thurin
Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland

Ena Wang
Division Chief of Translational Medicine, Sidra Medical and Research Centre, Doha, Qatar




For information please contact info@melanomabridge.org